China stocks have plummeted since last year, and valuations are now looking compelling, but tech titan Alibaba is no “value trap,” says portfolio manager Sid Choraria.
China stocks have plummeted since last year, and valuations are now looking compelling, but tech titan Alibaba is no “value trap,” says portfolio manager Sid Choraria.
Whether it’s more government spending or an interest rate cut, Goldman Sachs is expecting a range of policy support in China — and has stock picks for each policy.
Whether it’s more government spending or an interest rate cut, Goldman Sachs is expecting a range of policy support in China — and has stock picks for each policy.
The Federal Reserve raised benchmark interest rates 75 basis points on Wednesday in a move that equates to the most aggressive hike since 1994.
The Federal Reserve raised benchmark interest rates 75 basis points on Wednesday in a move that equates to the most aggressive hike since 1994.
U.S. stock index futures were modestly higher in overnight trading on Wednesday.
ETFs that bet against bonds or focus on floating rate products are beating the market this year.
The FDA will likely accept the recommendation and authorize the shots this week.
Scientists are building a micro nuclear reactor, which aims to be able to be significantly cheaper and faster to build than conventional light water reactors.